[
  {
    "ts": "2026-01-21T12:10:54+00:00",
    "headline": "Merck & Co (MRK) to Generate $70 Billion in Revenue from Emerging Businesses By Mid-2030s",
    "summary": "Merck & Co., Inc. (NYSE:MRK) is one of the best undervalued wide moat stocks. With competition rising to the company’s cancer therapy Keytruda, Merck & Co., Inc. (NYSE:MRK) is setting itself up for long-term growth. On January 12, 2026, the company raised its outlook for new growth drivers. Accordingly, Merck projects $70 billion in revenue […]",
    "url": "https://finance.yahoo.com/news/merck-co-mrk-generate-70-121054424.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "d0985755-b7b4-3dca-bccf-9f65ada2d98f",
      "content": {
        "id": "d0985755-b7b4-3dca-bccf-9f65ada2d98f",
        "contentType": "STORY",
        "title": "Merck & Co (MRK) to Generate $70 Billion in Revenue from Emerging Businesses By Mid-2030s",
        "description": "",
        "summary": "Merck & Co., Inc. (NYSE:MRK) is one of the best undervalued wide moat stocks. With competition rising to the company’s cancer therapy Keytruda, Merck & Co., Inc. (NYSE:MRK) is setting itself up for long-term growth. On January 12, 2026, the company raised its outlook for new growth drivers. Accordingly, Merck projects $70 billion in revenue […]",
        "pubDate": "2026-01-21T12:10:54Z",
        "displayTime": "2026-01-21T12:10:54Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/2599eaa3ebd7014f60b50968b758cbd7",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Merck & Co (MRK) to Generate $70 Billion in Revenue from Emerging Businesses By Mid-2030s ",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6RdHqnIaUyPg6ymCeQ_LNA--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/2599eaa3ebd7014f60b50968b758cbd7.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fJfT7.tyQe1oBafYUeZwEA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/2599eaa3ebd7014f60b50968b758cbd7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/merck-co-mrk-generate-70-121054424.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/merck-co-mrk-generate-70-121054424.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "RVMD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-21T12:10:47+00:00",
    "headline": "Broader Analyst Sentiment Bullish on Merck & Co. (MRK) Amid Tempered Short-Term Expectation and Long-Term Optimism",
    "summary": "Merck & Co., Inc. (NYSE:MRK) is included in our list of the 10 Goldman Sachs undervalued stocks to invest in. As of January 16, 2026, analyst sentiment on Merck & Co., Inc. (NYSE:MRK) stands broadly constructive, with roughly 60% of analysts bullish. However, the $115.00 consensus price target implies a modest 3.60% upside. The broader […]",
    "url": "https://finance.yahoo.com/news/broader-analyst-sentiment-bullish-merck-121047991.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "9dca171d-161d-3d19-80c5-1313b8ad9a1f",
      "content": {
        "id": "9dca171d-161d-3d19-80c5-1313b8ad9a1f",
        "contentType": "STORY",
        "title": "Broader Analyst Sentiment Bullish on Merck & Co. (MRK) Amid Tempered Short-Term Expectation and Long-Term Optimism",
        "description": "",
        "summary": "Merck & Co., Inc. (NYSE:MRK) is included in our list of the 10 Goldman Sachs undervalued stocks to invest in. As of January 16, 2026, analyst sentiment on Merck & Co., Inc. (NYSE:MRK) stands broadly constructive, with roughly 60% of analysts bullish. However, the $115.00 consensus price target implies a modest 3.60% upside. The broader […]",
        "pubDate": "2026-01-21T12:10:47Z",
        "displayTime": "2026-01-21T12:10:47Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/cb218414709808bf2f63f98ca522d436",
          "originalWidth": 1280,
          "originalHeight": 853,
          "caption": "Broader Analyst Sentiment Bullish on Merck & Co. (MRK) Amid Tempered Short-Term Expectation and Long-Term Optimism",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tXp3W2zDkWcbYHYM_edP3Q--~B/aD04NTM7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/cb218414709808bf2f63f98ca522d436.cf.webp",
              "width": 1280,
              "height": 853,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BuRra1_S02PEU8kqjSl2RA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/cb218414709808bf2f63f98ca522d436.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/broader-analyst-sentiment-bullish-merck-121047991.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/broader-analyst-sentiment-bullish-merck-121047991.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]